QNRX insider buying

2 cluster buys

Quoin Pharmaceuticals, Ltd. · Healthcare

When two or more insiders at Quoin Pharmaceuticals, Ltd. buy QNRX on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in QNRX plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters
2
Distinct insiders
7
Total bought
$809.7K
Market cap
$9.5M

Detected clusters

  • Dec 23 – Dec 23, 2024
    Detected Dec 23, 2024
    High conviction2 insiders
    Total bought
    $500.0K
    Market cap
    $9.5M
  • Sep 3 – Sep 10, 2024
    Detected Sep 10, 2024
    High conviction3 insiders
    Total bought
    $81.1K
    Market cap
    $9.2M

All notable open-market buys in QNRX

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

DateInsiderSharesPriceValueFiling
Oct 14, 2025
Director
15,152$8.49$128.6KSEC ↗
Dec 23, 2024
Director, Chief Operating Officer
555,556$0.45$250.0KSEC ↗
Dec 23, 2024
Director, Chief Executive Officer
555,556$0.45$250.0KSEC ↗
Dec 23, 2024
Chief Financial Officer
122,221$0.45$55.0KSEC ↗
Dec 23, 2024
Director
100,000$0.45$45.0KSEC ↗
Sep 10, 2024
Chief Financial Officer
10,000$0.91$9.1KSEC ↗
Sep 10, 2024
Chief Financial Officer
10,000$0.71$7.1KSEC ↗
Sep 9, 2024
Chief Financial Officer
4,000$0.80$3.2KSEC ↗
Sep 9, 2024
Chief Financial Officer
4,000$0.78$3.1KSEC ↗
Sep 9, 2024
Chief Financial Officer
856$0.80$684.8SEC ↗
Sep 4, 2024
Director, Chief Executive Officer
23,572$0.80$18.9KSEC ↗
Sep 4, 2024
Director, Chief Operating Officer
22,988$0.80$18.4KSEC ↗
Sep 4, 2024
Director, Chief Operating Officer
8,825$0.75$6.6KSEC ↗
Sep 4, 2024
Director, Chief Executive Officer
8,200$0.75$6.2KSEC ↗
Sep 4, 2024
Director, Chief Executive Officer
5,322$0.66$3.5KSEC ↗
Sep 3, 2024
Director, Chief Operating Officer
4,100$0.66$2.7KSEC ↗
Sep 3, 2024
Director, Chief Operating Officer
1,822$0.63$1.1KSEC ↗
Sep 3, 2024
Director, Chief Executive Officer
800$0.62$496.0SEC ↗

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare

QNRX insider buying — FAQ

Are insiders buying QNRX stock?
Yes — 7 distinct insiders have bought QNRX (Quoin Pharmaceuticals, Ltd.) on the open market, including 2 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Oct 15, 2025.
How much QNRX stock have insiders bought?
Insiders have bought a combined $809.7K of QNRX across 18 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in QNRX?
A cluster buy is two or more distinct Quoin Pharmaceuticals, Ltd. insiders — officers, directors, or 10% owners — each buying QNRX on the open market within a rolling window. QNRX has 2 detected cluster buys to date.
Where does this QNRX insider trading data come from?
Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in QNRX

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy QNRX within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding QNRX.